PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $15,553,382 | -27.4% | 402,833 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $21,426,687 | -8.8% | 402,833 | -0.1% | 0.01% | 0.0% |
| Q2 2022 | $23,500,847 | -26.0% | 403,102 | -3.2% | 0.01% | -14.3% |
| Q1 2022 | $31,776,672 | +34.9% | 416,361 | +6.3% | 0.01% | +40.0% |
| Q4 2021 | $23,557,000 | +62.1% | 391,508 | +50.9% | 0.01% | +66.7% |
| Q3 2021 | $14,533,000 | -20.3% | 259,526 | -13.7% | 0.00% | -25.0% |
| Q2 2021 | $18,241,000 | -30.4% | 300,604 | -19.6% | 0.00% | -33.3% |
| Q1 2021 | $26,207,000 | -7.1% | 373,900 | -20.7% | 0.01% | -14.3% |
| Q4 2020 | $28,203,000 | -0.5% | 471,312 | 0.0% | 0.01% | -12.5% |
| Q3 2020 | $28,335,000 | -0.5% | 471,312 | -13.1% | 0.01% | 0.0% |
| Q2 2020 | $28,474,000 | +56.9% | 542,667 | +0.3% | 0.01% | +33.3% |
| Q1 2020 | $18,147,000 | -26.0% | 541,213 | 0.0% | 0.01% | -14.3% |
| Q4 2019 | $24,517,000 | +13.8% | 541,213 | -4.4% | 0.01% | 0.0% |
| Q3 2019 | $21,550,000 | -9.8% | 566,051 | +3.0% | 0.01% | 0.0% |
| Q2 2019 | $23,900,000 | +42.7% | 549,551 | +24.9% | 0.01% | +40.0% |
| Q1 2019 | $16,752,000 | -6.4% | 440,137 | +5.7% | 0.01% | -28.6% |
| Q4 2018 | $17,905,000 | -2.5% | 416,208 | +11.4% | 0.01% | +16.7% |
| Q3 2018 | $18,371,000 | +137.7% | 373,781 | +55.0% | 0.01% | +100.0% |
| Q2 2018 | $7,730,000 | -39.4% | 241,188 | -41.1% | 0.00% | -40.0% |
| Q1 2018 | $12,758,000 | -22.4% | 409,566 | +13.7% | 0.01% | -16.7% |
| Q4 2017 | $16,437,000 | +21.6% | 360,068 | 0.0% | 0.01% | +20.0% |
| Q3 2017 | $13,521,000 | -21.3% | 360,068 | 0.0% | 0.01% | -28.6% |
| Q2 2017 | $17,175,000 | +13.4% | 360,068 | +8.4% | 0.01% | +16.7% |
| Q1 2017 | $15,149,000 | +14.3% | 332,219 | -19.1% | 0.01% | 0.0% |
| Q4 2016 | $13,258,000 | -1.2% | 410,467 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $13,416,000 | +26.4% | 410,467 | +30.4% | 0.01% | +20.0% |
| Q2 2016 | $10,618,000 | -4.8% | 314,785 | +49.6% | 0.01% | 0.0% |
| Q1 2016 | $11,152,000 | -26.3% | 210,487 | +6.8% | 0.01% | -37.5% |
| Q4 2015 | $15,132,000 | +174.0% | 197,059 | +46.7% | 0.01% | +166.7% |
| Q3 2015 | $5,522,000 | -48.7% | 134,350 | -11.7% | 0.00% | -40.0% |
| Q2 2015 | $10,757,000 | -20.4% | 152,109 | 0.0% | 0.01% | -28.6% |
| Q1 2015 | $13,515,000 | -10.1% | 152,109 | -10.3% | 0.01% | -12.5% |
| Q4 2014 | $15,031,000 | +27.8% | 169,536 | +39.7% | 0.01% | +33.3% |
| Q3 2014 | $11,762,000 | -47.2% | 121,356 | -50.0% | 0.01% | 0.0% |
| Q2 2014 | $22,296,000 | – | 242,712 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |